1 not yet recruiting, 1 unknown. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
Follow Active Genomes Expressed Diagnostics, Corp: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AGED Diagnostics Clinical Validation Study MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) | Not yet recruiting | Active Genomes Expressed Diagnostics, Corp | 500 | 2026-10-15 | 2026-10-09 | |
| AGED Diagnostics Liver Disease Assessment AGED Multiple Target Assay in Healthy Controls, AGED Multiple Target Assay in NAFLD Participants, AGED Multiple Target Assay in Fibrosis Participants - NASH With Fibrosis, NAFLD | Early Phase 1 | Unknown | Active Genomes Expressed Diagnostics, Corp | 400 | 2024-05-15 | 2024-04-04 |
Fibrosis (1) · Non-alcoholic Fatty Liver Disease (1)
United States (2)
Rachel E Zayas (1)